The certification process, backed by Cantourage as a sponsor, allows for the direct import of finished products from Canada. This regulatory milestone transforms a long-standing business relationship into a more agile supply chain, effectively bypassing previous logistical bottlenecks. By shifting specific production steps to certified partners, Cantourage gains the capacity needed to scale its premium portfolio across the European Union and the United Kingdom.
Jen-Frederick Nadeau, CEO of Green Karat, noted that the certification provides the foundation to reach patients more rapidly. Philip Schetter, CEO of Cantourage, emphasized that this move serves as a blueprint for the company's broader growth strategy. By diversifying its production footprint, Cantourage reduces dependency on single-source suppliers and mitigates supply-chain risks. The company is currently guiding several other international producers through similar certification processes, with completion expected by the end of 2026.
Comments (0)
No comments yet. Be the first!